Sicagen India Ltd.

BSE: 533014

Strong Performer, Under Radar

Download real time

66.57 0.95 (1.45%)

43.96% Fall from 52W High

7,743 BSE Volume

BSE 30 May, 2025 3:31 PM (IST)

263.4

Market Cap

High in industry

1.4

Beta 1Year

Very High Volatility

Sicagen India Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Sicagen India Ltd. on BSE

Search Inside the pdf :

Sicagen India Ltd.

27 May 2025

66.57

1.45%

Company Update

Sicagen India Ltd - 533014 - Compliances-Reg.24(A)-Annual Secretarial Compliance

BSE India

Annual Secretarial Compliance Report for the year ended 31st March, 2025.

Sicagen India Ltd.

12 May 2025

66.57

1.45%

Company Update

Sicagen India Ltd - 533014 - Announcement under Regulation 30 (LODR)-Change in Management

BSE India

Appointment/Re-appointment of Internal Auditor, Cost Auditor & Secretarial Auditor.

Sicagen India Ltd.

12 May 2025

66.57

1.45%

Company Update

Sicagen India Ltd - 533014 - Equity Dividend For The FY 2024-25.

BSE India

Declaration of equity dividend for the FY 2024-25.

Sicagen India Ltd.

12 May 2025

66.57

1.45%

Result

Sicagen India Ltd - 533014 - Audited Financial Results For The Quarter & Year Ended 31.03.2025.

BSE India

Audited Financial Results (both Standalone & Consolidated) of the Company for the quarter & year ended on 31.03.2025 together with the Auditors Report thereon.

	Mar 2025	Dec 2024	Mar 2024	Change QoQ%	Change YoY%
Total Revenue Qtr	253.92	213.52	222.67	18.9%	14.0%
Operating Profit Qtr	10.74	7.14	8.38	50.4%	28.2%
Net Profit Qtr	3.97	4.20	3.07	-5.5%	29.3%
Earning Per Share Adjusted latest Qtr	1.00	1.06	0.78	-5.7%	28.2%

* Consolidated data

Detailed Results

Sicagen India Ltd.

12 May 2025

66.57

1.45%

Board Meeting

Sicagen India Ltd - 533014 - Board Meeting Outcome for Outcome Of Board Meeting Held On …

BSE India

In the meeting of Board of Directors of the Company held on 12.05.2025 i.e. today, the Board has inter-alia considered and approved the Audited Financial Results (both Standalone & Consolidated) of the Company for the Quarter and year ended 31st March, 2025 together with the Auditors Report thereon. The Board has also recommended 10% Equity Dividend (One rupee per share) on Equity Capital of the Company for the Financial Year 2024-25.

Sicagen India Ltd.

02 May 2025

66.57

1.45%

Board Meeting

Sicagen India Ltd - 533014 - Board Meeting Intimation for Consideration And Approval Of The Audited …

BSE India

Sicagen India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/05/2025 ,inter alia, to consider and approve the Audited Financial Results (both Standalone & Consolidated) of the Company for the Quarter & year ended 31st March, 2025 and recommend the Equity Dividend (If Any) for the Financial Year 2024-25.

Sicagen India Ltd.

16 Apr 2025

66.57

1.45%

Company Update

Sicagen India Ltd - 533014 - Announcement under Regulation 30 (LODR)-Change in Management

BSE India

Intimation about appointment of Senior Management Personnel.

Sicagen India Ltd.

09 Apr 2025

66.57

1.45%

Company Update

Sicagen India Ltd - 533014 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

BSE India

Certificate under Regulation 74(5) of SEBI (Depositories & Participants) Regulations, 2018 for the quarter ended 31st March, 2025.

Sicagen India Ltd.

08 Apr 2025

66.57

1.45%

Company Update

Sicagen India Ltd - 533014 - Announcement under Regulation 30 (LODR)-Change in Management

BSE India

Intimation regarding Change in Senior Management Personnel.

Sicagen India Ltd.

27 Mar 2025

66.57

1.45%

SAST

Sicagen India Ltd - 533014 - Closure of Trading Window

BSE India

Intimation of Trading window closure for the quarter & year ended 31st March, 2025.

Is Sicagen India Ltd. worth buying?

89 Votes:

Buy 88.76%

Sell 7.87%

Hold 3.37%